Skip to content

The Outcome and Influence Factors of Assisted Reproductive Therapy in Patients With Cesarean Scar Uterus.

A Prospective Case-control Study of the Outcome and Influence Factors of Assisted Reproductive Therapy in Patients With Cesarean Scar Uterus.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04070222
Enrollment
120
Registered
2019-08-28
Start date
2019-08-01
Completion date
2023-04-30
Last updated
2019-12-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertile Patients With Previous Live Birth

Keywords

Secondary infertility, cesarean section, post-cesarean section scar diverticulum , endometrial microflora, inflammatory markers, clinical pregnancy, live birth

Brief summary

Mode of delivery affects the success rate of assisted reproductive techniques (ART). In this case study, the investigators will evaluate changes in the bacterial ecology and inflammatory markers of the female uterus with different delivery modes. We will investigate whether the dominate endometrial microflora is interrupted by the Cesarean section in the infertile women undergoing ART, and the potential mechanism will also be further explored prospectively.

Detailed description

The highly prevalence of cesarean section rate in China had drawn great attention world widely. Post-cesarean section scar diverticulum ( PCSD) is a poor healing of the local incision after Cesarean section which happened in19.4%\ 88% of patients. The cavity is formed by the original incision connected with the uterine cavity. Patients with diverticulum are often accompanied by prolonged menstruation and uterine effusion, which may accompany with endometrial inflammation and impair embryo implantation rate. Though Cesarean section plays an important role in the treatment of dystocia and also decreasing perinatal mortality, it may impact natural conception and the success rate of ART in secondary infertile patients. Data from other researchers have revealed that Cesarean scar may related to poor pregnancy outcome during ART treatment. We have retrospectively analyzed the pregnancy outcome of ART treatment in patients who have had live birth previously from January 2014 to May 2018. The biochemical pregnancy rate, embryo implantation rate and clinical pregnancy rate are all lower in patients with Caesarean section compared to patients after natural labour, the clinical data is even worse in patients with PCSD. The results suggest a close correlation between the outcome of assisted reproductive therapy and the uterine condition. Further evaluations are required related to whether the dominate endometrial microflora is interrupted by the Cesarean section in the infertile women undergoing ART, and the potential mechanism will also be explored accordingly. A single-center, prospective, case-control study will be carried out.

Interventions

OTHERHysteroscopy

1. Three groups of patients will be enrolled: Natural labour group, Cesarean scar group and Cesarean with diverticulum (PCSD) group; 2. Hysteroscopy will be carried out for uterine cavity examine and the specimen collection for further microflora analysis and inflammation marker detection; 3. ART will be carried out with standard protocol and the clinical outcome will be recorded; 4. The primary outcome of the study is the comparation of species and communities of uterine microflora and inflammatory markers of the female uterus among three groups. The secondary outcome is biochemical pregnancy rate, clinical pregnancy rate, embryo implantation rate and live birth rate.

Sponsors

Sun Yat-sen University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

1. Women age ≥20 years and ≤40 years. 2. infertile Women with previously live birth. 3. Previous failed transfer cycle ≤2 4. Didn't participate in other clinical subjects within three months. 5. Written informed consent.

Exclusion criteria

1. surgery history including: Ovariectomy, myomectomy, adenomyomectomy. 2. Uterine diseases including: uterine malformation, submucosal uterine fibroids and intrauterine adhesion. 3. One of couple has abnormal karyotype. 4. Recurrent abortion ≥2. 5. Untreated hydrosalpinx. 6. History of tuberculosis (pulmonary tuberculosis, pelvic tuberculosis etc.).

Design outcomes

Primary

MeasureTime frameDescription
Species and communities of uterine microflora1-2 yearUse the swab to scrape endometrium. Characterization of species and communities of uterine microflora will use bacterial DNA microarray analysis. Normally, the uterine cavity used to being thought a sterile space.
Inflammatory markers of the female uterus1-2 yearUse the swab to scrape endometrium. Characterization of inflammatory markers of the female uterus will use human cytokines measuring. The cytokines will include IL2,IL4,SDF-1α , etc. Use the natural labor group as control group, and see differentiation among the three group.

Secondary

MeasureTime frameDescription
Clinical pregnancy rate1-2 yearClinical pregnancy means pregnancy sac is seen intrauterine under ultrasound 7 weeks after embryo transferred. Clinical pregnancy rate(%): number of clinical pregnancy/transferred cycle.
Biochemical pregnancy rate1-2 yearBiochemical pregnancy rate(%): number of biochemical pregnancy/transferred cycle.
Embryo implantation rate1-2 yearEmbryo implantation rate(%): number of gestational sac / transferred embryo.
Live birth rate1-2 yearLive birth rate(%): number of live birth/ transferred cycle.

Countries

China

Contacts

Primary ContactXing Yang, M.D. & Ph.D
yxing_8358@126.com020-38048013
Backup ContactXing Yang, M.D. & Ph.D
020-38048010

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026